New blood test could revolutionize breast cancer screening
NCT ID NCT07219277
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study is testing a new blood test that aims to find breast cancer early in women aged 30 to 75. Researchers will check how well the test works in 2,000 women from different backgrounds. If accurate, it could make screening easier and more accessible for everyone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Syantra blood test (liquid biopsy)
- What this could lead to
- If successful, this blood test could become a simple, widely available screening tool to catch breast cancer earlier, potentially saving lives.
- What could go wrong
- This is a validation study, not a treatment trial. The test may not be accurate enough for all groups, and false positives or negatives could occur.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER, LIQUID BIOPSY, EARLY DETECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alberta Cancer Research Biobank
ACTIVE_NOT_RECRUITINGCalgary, Alberta, T2N 5G2, Canada
-
Manchester University NHS Foundation Trust
NOT_YET_RECRUITINGManchester, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Vincere Cancer Center
RECRUITINGPhoenix, Arizona, 85260, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Weill Cornell Medicine of Cornell University
NOT_YET_RECRUITINGNew York, New York, 10065, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••